ARROWHEAD PHARMACEUTICALS, INC.
ARWR · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Olukotun Adeoye Y: Form 4
Insider disclosure · Filed · Report period 18 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000879407 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ARWR on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 177 E Colorado Blvd, Suite 700, Pasadena, CA, 91105
- Incorporated in
- DE
- Fiscal year end
- 30 September
- Former names on EDGAR
- ARROWHEAD RESEARCH CORP (to 06 Apr 2016), INTERACTIVE GROUP INC (to 09 Jan 2004), INTERACTIVE INC (to 13 Feb 2002)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields